Literature DB >> 8893148

Mechanisms of hyperuricemia in cyclosporine-treated renal transplanted children.

J Laine1, C Holmberg.   

Abstract

Mechanisms of hyperuricemia were investigated in 19 pediatric renal transplant recipients 6 months after transplantation. 51Cr-EDTA, PAH, lithium and sodium clearances, 24-hour urinary creatinine and urate excretions were measured. Ten patients had hyperuricemia. The hyperuricemic patients had lower EDTA, PAH, and urate clearances (mean 69.5 vs. 92.5, p < 0.05, 234 vs. 421, p < 0.05 and 4.3 vs. 10.6 ml/min/1.73 m2, p < 0.001, respectively). Serum urate concentration correlated with cyclosporine dose (r = 0.46, p < 0.05) and inversely with urate (r = -0.88, p < 0.001), and lithium (r = -0.55, p < 0.05) clearances. Urate clearance showed a significant positive correlation with lithium clearance (r = 0.66, p = 0.01) and an inverse correlation with fractional proximal tubular reabsorption (r = -0.63, p = 0.02). Results were not influenced by diuretic administration. Our data support increased proximal tubular urate reabsorption rather than decreased secretion as the mechanism in cyclosporine-induced hyperuricemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8893148     DOI: 10.1159/000189328

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  8 in total

1.  Hyperuricemia and gout following pediatric renal transplantation.

Authors:  Giuseppina Spartà; Markus J Kemper; Thomas J Neuhaus
Journal:  Pediatr Nephrol       Date:  2006-09-01       Impact factor: 3.714

Review 2.  Gout in solid organ transplantation: a challenging clinical problem.

Authors:  Lisa Stamp; Martin Searle; John O'Donnell; Peter Chapman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Use of uric acid-lowering agents limits experimental cyclosporine nephropathy.

Authors:  Fernanda Cristina Mazali; Richard J Johnson; Marilda Mazzali
Journal:  Nephron Exp Nephrol       Date:  2011-11-25

4.  Uric acid stones following hepatic transplantation.

Authors:  Mei-Tsuey Hwang; David S Goldfarb
Journal:  Urol Res       Date:  2004-11-25

5.  Hyperuricemia beyond 1 year after kidney transplantation in pediatric patients: Prevalence and risk factors.

Authors:  B Einollahi; H Einollahi; Z Rostami
Journal:  Indian J Nephrol       Date:  2012-07

Review 6.  Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient.

Authors:  A G Fam
Journal:  Curr Rheumatol Rep       Date:  2001-02       Impact factor: 4.686

7.  Prevalence and risk factors of hyperuricemia among kidney transplant recipients.

Authors:  B Einollahi; H Einollahi; M Nafar; Z Rostami
Journal:  Indian J Nephrol       Date:  2013-05

Review 8.  Expert consensus on management of metabolic disease in Chinese liver transplant recipients.

Authors:  Tian Shen; Li Zhuang; Xiao-Dong Sun; Xiao-Sheng Qi; Zhi-Hui Wang; Rui-Dong Li; Wen-Xiu Chang; Jia-Yin Yang; Yang Yang; Shu-Sen Zheng; Xiao Xu
Journal:  World J Gastroenterol       Date:  2020-07-21       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.